285 results on '"Enooku, Kenichiro"'
Search Results
2. Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis
3. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals
4. Machine Learning–Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation
5. Radiofrequency Ablation of Liver Tumors in Patients on Antithrombotic Therapy: A Case-Control Analysis of over 10,000 Treatments
6. Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma
7. Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital
8. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients
9. A Novel Non-invasive Method for Predicting Liver Fibrosis by Quantifying the Hepatic Vein Waveform
10. Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
11. Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation
12. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells
13. Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis
14. Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
15. Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism
16. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
17. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease
18. Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
19. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
20. Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients
21. Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
22. Comparison of improved prognosis between hepatitis B- and hepatitis C-related hepatocellular carcinoma
23. Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma
24. Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography
25. Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients
26. Perihepatic lymph node enlargement is a negative predictor of liver cancer development in chronic hepatitis C patients
27. Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma
28. Characteristics of hepatocellular carcinoma nodules newly detected by computed tomography during arteriography and arterial portography: preliminary report of a randomized controlled trial
29. Evaluation of molecular targeted cancer drug by changes in tumor marker doubling times
30. Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation
31. Spontaneous clearance of serum hepatitis C virus RNA during the clinical course of hepatocellular carcinoma in patients with chronic hepatitis C
32. Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients
33. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential
34. Perihepatic lymph node enlargement is a negative predictor for sustained responses to pegylated interferon-α and ribavirin therapy for Japanese patients infected with hepatitis C virus genotype 1
35. Perihepatic lymph node enlargement observed at a general health examination: A cross-sectional study
36. Plasma lysophosphatidic acid levels and hepatocellular carcinoma
37. Frequency and Predictive Factors of Vascular Invasion after Curative Treatment for Hepatocellular Carcinoma by Radiofrequency Ablation: 578
38. Sorafenib for advanced hepatocellular carcinoma: Comparison with systemic combination therapy of intravenous continuous 5-fluorouracil and pegylated interferon as a historical control: 555
39. Predicting disease progression of recurrent tumor after radiofrequency ablation in patients with hepatocellular carcinoma: 528
40. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients
41. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet
42. Difference between antinuclear antibody-positive non-alcoholic steatohepatitis and autoimmune hepatitis based on differential patterns of peripheral T lymphocytes
43. Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volume
44. Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
45. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients
46. Ischemic complications after percutaneous radiofrequency ablation of liver tumors: Liver volume loss and recovery
47. Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessment
48. Helicobacter pyloriinfection and liver diseases: Epidemiology and insights into pathogenesis
49. Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
50. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.